Pharsight

INTAS PHARMACEUTICALS PATENTS FACING OPPOSITIONS

Top patents of INTAS PHARMACEUTICALS facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3833335B1 31 Aug, 2022 Pharmaceutical Composition Comprising Hmg-Coa Reductase Inhibitors And Fenofibrate Jul, 2040 1
EP2978426B1 13 Nov, 2019 Stable Tigecycline Composition NA 1
EP2917192B1 20 Mar, 2019 Process For The Preparation Of Cabazitaxel And Its Intermediates NA 1